Hospitals.net
Explore
FollowingSign In

Hospitals.net

The network behind healthcare.

Directory

  • Explore
  • Hospitals
  • Clinics
  • For professionals

Resources

  • Conditions
  • Medications
  • Supplements
  • Health resources
  • Medical procedures
  • Online care

Company

  • About
  • Contact
  • Privacy
  • Terms
  • Disclaimer

© 2026 Hospitals.net

United States/Canada
Rinvoq - Drug Information

Rinvoq

📚Health Resources
🔎Find Hospitals NearbyFind Hospitals📷Images

Drug Class

JAK inhibitor

Type

brand

Active Ingredient

upadacitinib

Educational overview only. This page summarizes publicly available information about Rinvoq for general understanding. For full prescribing details, consult official labeling or a healthcare professional.

📋Overview

Rinvoq contains the active ingredient upadacitinib and belongs to a class of drugs known as Janus kinase (JAK) inhibitors. It works by interfering with specific signaling pathways in the body that contribute to inflammation and overactive immune responses.

By blocking these pathways, the medication helps to reduce the underlying processes that cause swelling, pain, and tissue damage in certain chronic conditions.

Share

📚References

Upadacitinib

Information from MedlinePlus.gov (NIH).

Found an Error?

Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.

Find Discounts for Rinvoq

Hospitals.net Disclosure

Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.

Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.